Sterne Kessler Goldstein Fox

	

	



		

			

					

				Video
				Play
			

		
					

				
 
"The IAM Strategy 250 identifies individuals who offer world-class services related to the development and implementation of strategies which enable IP owners to maximise the value of their rights portfolios"
-Joff Wild, Editor, IAM Magazine 
 
IAM patent 1000 logo
"One of the best biotechnology lawyers in the country"
- IAM Patent 1000 2013
 
			

		
		

	


	

		

			
"A real authority whose advice
is like gold dust."
 
 
 
–Chambers USA 
 
 
 
		


		


			

			
		

	
	


	


	

	

		

			

				
Mind + Muscle


				


				

				


					

						
Jorge A. Goldstein, Ph.D.
						
Director
					


					
 


				


				


				

									


			


			

				

					
				


				


				

					
A Pioneer in Biotechnology Patent Law
He is considered by his peers and clients to be one of the country’s pioneers in biotechnology patent law. He has more than thirty years’ experience in the preparation and prosecution of patent applications before the U.S. and foreign patent offices in scientific areas such as genomics, molecular and cell biology, recombinant DNA technology, immunology, transgenics, therapeutic methods, stem cells, organic synthesis, pharmaceuticals and polymers.

Leads the Sterne Kessler Biotech and Pro Bono Practices
Jorge heads both the firm’s Biotechnology Practice Group and the Intellectual Property and Human Rights Pro Bono Practice. He has handled multiple and varied interferences over many years, including successful appeals to the Court of Appeals for the Federal Circuit. He chairs the firm’s Inventorship Dispute Resolution Service and serves as a Neutral Mediator/Arbitrator as part of Ocean Tomo’s ADR Service. He has also been involved in oppositions, and arbitrations in District Court and in Appellate litigation both as counsel and expert witness, and in counseling clients on intellectual property strategy, trade secrets, licensing, research contracts, university-industry relations, federal licensing, due diligence, acquisitions and employment agreements. He was lead counsel in the 1988 appellate case of In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement requirements.
He has also been named Extraordinary Professor of Law by the Universidad Austral in Buenos Aires, Argentina, where he teaches biotech patent law in the only WIPO-certified regional master's IP program in Latin America. 
				


				

					
Dr. Goldstein's achievements include:
  • Best Lawyers' 2013 Washington DC Biotechnology Law 'Lawyer of the Year'
  • Leading Lawyer in Intellectual Property, Chambers USA, 2006-2011
  • Washington DC Super Lawyers 2008-2011  
  • International Who's Who of Patent Lawyers 2011 
  • IAM 250 - Leading Life Science Lawyer, 2010
  • Best Lawyers in America, 2008-2013
  • Leading Lawyer in the Life Sciences, Chambers USA, 2007-2010
  • Judge for annual Law Practice Magazine EDGE Awards 2008-2009 
  • Certified Licensing Professional 2008
  • Martindale Hubble Peer-Review Rating: AV
  • Key Figure in Interferences, The Legal 500 United States, 2007-2008
  • Legal Elite, SmartCEO, 2006
  • Leading lawyer in the Life Sciences/in IP, Legal Times, 2006, 2003
  • Order of the Coif, George Washington University Law School, 1982
  • Excellence in Teaching of Chemistry, Harvard University, 1972, 1974
  • Class of 1902 Research Prize, Rensselaer Polytechnic Institute, 1971
Technical Publications
"Biotechnology  Patent Pools and Standard Setting," Chapter in Patent Law: A Handbook  of Contemporary Research, Edward Elgar Publishing.
“In  re Wands Turns 20 This Year and is  Increasingly Influencing the  Written Description Requirement in Biotechnology,” IP Today, August  2008, pages 1-3.
"Patentes Respecto de Genes Humanos,"  4 Anuario Andino de   Derechos Intelectuales 173 (Lima, Peru 2008.)
"Scientific Collaborations and Inventorship Disputes," 12 IP Litigator 18, November/December 2006. 
 
				


			
    

							
  • Admissions
					
      
											
    • District of Columbia
      • 
											
    • United States Patent and Trademark Office
      • 
											
    • Court of Appeals for the Federal Circuit
      • 
										
    
				
    • 
			
							
  • Representative Matters
                        		
    
                       	        	
    Dr. Goldstein's achievements include:
    • Best Lawyers' 2013 Washington DC Biotechnology Law 'Lawyer of the Year'
    • Leading Lawyer in Intellectual Property, Chambers USA, 2006-2011
    • Washington DC Super Lawyers 2008-2011  
    • International Who's Who of Patent Lawyers 2011 
    • IAM 250 - Leading Life Science Lawyer, 2010
    • Best Lawyers in America, 2008-2013
    • Leading Lawyer in the Life Sciences, Chambers USA, 2007-2010
    • Judge for annual Law Practice Magazine EDGE Awards 2008-2009 
    • Certified Licensing Professional 2008
    • Martindale Hubble Peer-Review Rating: AV
    • Key Figure in Interferences, The Legal 500 United States, 2007-2008
    • Legal Elite, SmartCEO, 2006
    • Leading lawyer in the Life Sciences/in IP, Legal Times, 2006, 2003
    • Order of the Coif, George Washington University Law School, 1982
    • Excellence in Teaching of Chemistry, Harvard University, 1972, 1974
    • Class of 1902 Research Prize, Rensselaer Polytechnic Institute, 1971
    Technical Publications
    "Biotechnology  Patent Pools and Standard Setting," Chapter in Patent Law: A Handbook  of Contemporary Research, Edward Elgar Publishing.
    “In  re Wands Turns 20 This Year and is  Increasingly Influencing the  Written Description Requirement in Biotechnology,” IP Today, August  2008, pages 1-3.
    "Patentes Respecto de Genes Humanos,"  4 Anuario Andino de   Derechos Intelectuales 173 (Lima, Peru 2008.)
    "Scientific Collaborations and Inventorship Disputes," 12 IP Litigator 18, November/December 2006. 
     
                            		
    
				
    • 
			
							
  • Education
					
				
    • 
			
							
  • Achievements
				
    • IAM Patent 1000 2013 Recommended Lawyer
    • Best Lawyers' 2013 Washington DC Biotechnology Law 'Lawyer of the Year'
    • 2012 LMG Life Sciences ‘Star’ 
    • Washington DC Super Lawyers 2008-2012
    • Leading Lawyer in IP, Chambers USA, 2006-2012
    • International Who's Who of Patent Lawyers 2011 
    • IAM 250 - Leading Life Science Lawyer, 2010
    • Best Lawyers in America  2008-2013
    • Leading Lawyer in the Life Sciences, Chambers USA, 2007-2012
    • Key Figure in Interferences, The Legal 500 U.S., 2007-2008
    • Certified Licensing Professional 2008
    • Martindale AV Preeminent Peer Rating 5.0/5.0
    				
    • 
			

							
  • Memberships
					
      
											
    • American Association for the Advancement of Science
      • 
											
    • American Chemical Society
      • 
											
    • American Intellectual Property Law Association Biotechnology Committee
      • 
											
    • Biotechnology Industry Association
      • 
										
    
				
    •